These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 17764997)

  • 1. Analysis of CYP2D6 substrate interactions by computational methods.
    Ito Y; Kondo H; Goldfarb PS; Lewis DF
    J Mol Graph Model; 2008 Feb; 26(6):947-56. PubMed ID: 17764997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of ionic interactions and protein dynamics to cytochrome P450 2D6 (CYP2D6) substrate and inhibitor binding.
    Wang A; Stout CD; Zhang Q; Johnson EF
    J Biol Chem; 2015 Feb; 290(8):5092-5104. PubMed ID: 25555909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 7-methoxy-4-(aminomethyl)-coumarin to wild-type and W128F mutant cytochrome P450 2D6 studied by time-resolved fluorescence spectroscopy.
    Stortelder A; Keizers PH; Oostenbrink C; De Graaf C; De Kruijf P; Vermeulen NP; Gooijer C; Commandeur JN; Van der Zwan G
    Biochem J; 2006 Feb; 393(Pt 3):635-43. PubMed ID: 16190863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6.
    McCarty KD; Ratliff SA; Furge KA; Furge LL
    Drug Metab Dispos; 2021 Mar; 49(3):179-187. PubMed ID: 33376147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous Ligand Access Events to Membrane-Bound Cytochrome P450 2D6 Sampled at Atomic Resolution.
    Fischer A; Smieško M
    Sci Rep; 2019 Nov; 9(1):16411. PubMed ID: 31712722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Conserved Allosteric Site on Drug-Metabolizing CYPs: A Systematic Computational Assessment.
    Fischer A; Smieško M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms Underlying Single Nucleotide Polymorphism-Induced Reactivity Decrease in CYP2D6.
    Becker D; Bharatam PV; Gohlke H
    J Chem Inf Model; 2024 Aug; 64(15):6026-6040. PubMed ID: 38994927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Lipid Bilayer Anchoring on the Conformational Properties of the Cytochrome P450 2D6 Binding Site.
    Guvench O
    J Phys Chem B; 2024 Jul; 128(29):7188-7198. PubMed ID: 39016537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP 2D6 binding affinity predictions using multiple ligand and protein conformations.
    Perić-Hassler L; Stjernschantz E; Oostenbrink C; Geerke DP
    Int J Mol Sci; 2013 Dec; 14(12):24514-30. PubMed ID: 24351831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions studies of CYP2D6 with quercetin and hyperoside by spectral analysis and molecular dynamics simulations.
    Wang M; Wang S; Cui J; Lian D; Li Y; Du Y; Li L
    Luminescence; 2024 Jan; 39(1):e4605. PubMed ID: 37795938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Ligand Binding Hot Spots of the Histamine H
    Kuhne S; Kooistra AJ; Bosma R; Bortolato A; Wijtmans M; Vischer HF; Mason JS; de Graaf C; de Esch IJ; Leurs R
    J Med Chem; 2016 Oct; 59(19):9047-9061. PubMed ID: 27643714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to chinese herbal medicine screening.
    Mo SL; Liu WF; Li CG; Zhou ZW; Luo HB; Chew H; Liang J; Zhou SF
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1640-704. PubMed ID: 22039821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the human histamine H1 receptor complex with doxepin.
    Shimamura T; Shiroishi M; Weyand S; Tsujimoto H; Winter G; Katritch V; Abagyan R; Cherezov V; Liu W; Han GW; Kobayashi T; Stevens RC; Iwata S
    Nature; 2011 Jun; 475(7354):65-70. PubMed ID: 21697825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histamine H1-receptor antagonist binding site. A stereoselective pharmacophoric model based upon (semi-)rigid H1-antagonists and including a known interaction site on the receptor.
    ter Laak AM; Venhorst J; Donné-Op den Kelder GM; Timmerman H
    J Med Chem; 1995 Aug; 38(17):3351-60. PubMed ID: 7650688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsecond MD simulations of human CYP2D6 wild-type and five allelic variants reveal mechanistic insights on the function.
    Don CG; Smieško M
    PLoS One; 2018; 13(8):e0202534. PubMed ID: 30133539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Dynamics Simulations to Investigate the Influences of Amino Acid Mutations on Protein Three-Dimensional Structures of Cytochrome P450 2D6.1, 2, 10, 14A, 51, and 62.
    Fukuyoshi S; Kometani M; Watanabe Y; Hiratsuka M; Yamaotsu N; Hirono S; Manabe N; Takahashi O; Oda A
    PLoS One; 2016; 11(4):e0152946. PubMed ID: 27046024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationalization of stereospecific binding of propranolol to cytochrome P450 2D6 by free energy calculations.
    Nagy G; Oostenbrink C
    Eur Biophys J; 2012 Dec; 41(12):1065-76. PubMed ID: 23086294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical studies on the interaction of biphenyl inhibitors with Mycobacterium tuberculosis protein tyrosine phosphatase MptpB.
    Dong L; Shi J; Liu Y
    J Mol Model; 2012 Aug; 18(8):3847-56. PubMed ID: 22406969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivators.
    Livezey M; Nagy LD; Diffenderfer LE; Arthur EJ; Hsi DJ; Holton JM; Furge LL
    Drug Metab Lett; 2012 Mar; 6(1):7-14. PubMed ID: 22372551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted imidazole of 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Inactivates cytochrome P450 2D6 by protein adduction.
    Nagy LD; Mocny CS; Diffenderfer LE; Hsi DJ; Butler BF; Arthur EJ; Fletke KJ; Palamanda JR; Nomeir AA; Furge LL
    Drug Metab Dispos; 2011 Jun; 39(6):974-83. PubMed ID: 21422192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.